Investors

News Releases

Oct 17, 2017

Neothetics, Inc. and Evofem Biosciences, Inc. Announce Merger Agreement to Create Women’s Health Company
Jul 27, 2017

Evofem Biosciences Announces First Patient Enrolled in a Phase 3 Clinical Trial of AMPHORA® (L-lactic Acid, citric acid, and potassium bitartrate) for Prevention of Pregnancy
Jun 29, 2017

AMPHORA® (L-lactic Acid, citric acid, and potassium bitartrate) Receives "Qualified Infectious Disease Product" (QIDP) Designation from the FDA
Dec 16, 2016

Evofem Biosciences Appoints Dr. David Friend as Chief Scientific Officer
Aug 29, 2016

Evofem Biosciences Appoints Russell Barrans as Chief Commercial Officer
Aug 17, 2016

Evofem Biosciences Announces First Patient Enrolled in a Clinical Trial to Determine the Effect and Duration of Amphora Gel on Vaginal pH
Aug 4, 2016

Evofem secures $25 million in Series D funding

EVOFEM SECURES $25.0 MILLION IN SERIES D FUNDING
Jun 15, 2016

Evofem to Address the Cavendish Global Health Impact Forum at Biocom on Innovations in Reproductive Health Care around the globe.
May 16, 2016

Evofem and WomanCare Global to Attend Women Deliver 2016

Largest conference on health, rights, and wellbeing of girls and women with focus on solutions
Mar 31, 2016

Evofem Files IND for Evaluation of Prevention of Recurrence of Bacterial Vaginosis
Feb 9, 2016

Evofem and DKT to Develop Coated Condom
Jan 11, 2016

Evofem Holdings, Inc. Announces Successful Completion of Pre-IND Meeting for Amphora®
Jan 6, 2016

Evofem, Inc. Expands Management Team
Sep 22, 2015

Evofem, Inc. Announces FDA Acceptance of New Drug Application for Amphora™ as a Contraceptive
Jul 30, 2015

Evofem, Inc. Appoints Russell Barrans as Vice President of Sales and Marketing for North America
Jul 6, 2015

Evofem, Inc. Submits New Drug Application to U.S. FDA for Amphora™ as a Contraceptive
Jul 1, 2015

Evofem, Inc. Appoints Dr. Kelly Culwell as Chief Medical Officer
Apr 14, 2015

Woman Care Global & Evofem CEO Saundra Pelletier Announced as Speaker for UVA Darden School of Business’ Leadership Speaker Series
Apr 1, 2015

Evofem, Inc. Appoints Dr. David Friend as Senior Vice President of Product Development
Jan 13, 2015

Evofem, Inc. Announces Pre-NDA Meeting With FDA for Amphora™
Jun 26, 2014

Evofem Announces the Completion of a Phase III Contraceptive Clinical Trial

Show per page